NCT00035932 - Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV | Biotech Hunter

Enrollment

571

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

July 31, 2003

Study Completion Date

March 31, 2009

Conditions

HIV Infections

Interventions

DRUG

Atazanavir + ritonavir + tenofovir + nucleoside

Active Comparator, Capsules, tablets, Oral

DRUG

Atazanavir + saquinavir + tenofovir + nucleoside

Active Comparator, Capsules, tablets, Oral

DRUG

Lopinavir/ritonavir + tenofovir + nucleoside

Active Comparator, Capsules, tablets, Oral

Trial Locations (29)

10019

New York

11030

Manhasset

14215

Buffalo

14620

Rochester

27157

Winston-Salem

28078

Huntersville

29203

Winston-Salem

32801

Orlando

33160

Miami Beach

33306

Fort Lauderdale

33308

Fort Lauderdale

40202

Louisville

67214

Wichita

75246

Dallas

77006

Houston

80304

Boulder

90502

Torrance

94121

San Francisco

96816

Honolulu

Unknown

Altamonte Springs

Decatur

Boise

New Orleans

Brookline

East Orange

Akron

Dallas

02720

Fall River

07103

Newark